検索キーワード： 著者 "Canadian Hemophilia Society" すべてのカテゴリー

Innovation is accelerating—not only in communications, computer technology, and artificial intelligence, but also in medical science. For people living with inherited bleeding disorders, this acceleration is transforming what is possible.Over the past decade, treatment advances have reshaped care. Extended half-life factor VIII and IX concentrates have reduced infusion frequency. Factor VIII mimetics such as emicizumab have introduced entirely new mechanisms of action. The first gene therapies for hemophilia A and B are now a reality. Rebalancing agents have entered the therapeutic landscape...

Gene therapy has remained a constant prospect in the sphere of hemophilia treatment. For over two decades and the question remained: Is this just a dream, or could it one day become a reality?Hemophilia gene therapy has finally been approved.David Page talks to hemophilia specialists that will dive deep into understanding how the treatment works, its significance in advancing treatment, and how a one time treatment could change a severe condition to a milder one.Though not a definitive cure, gene therapy for hemophilia has transformed the dream of a cure into a reality for the future.David and...